OrthoTec Europe Conference Features Insights into Chinese Market
The challenges and opportunities of doing business in emerging markets will be the focus of a highly anticipated conference session at OrthoTec Europe 2012, taking place 12 and 13 September in Zürich, Switzerland. Participating on the panel, Zeli Yu, Vice President of Shanghai Hail Fellow Medical Device Scientific Technology Co. Ltd, an IVD distribution company, will discuss strategies for penetrating the Chinese market.
Drawing on years of experience serving with a Notified Body and providing regulatory consulting services related to US FDA quality systems inspections, Yu will compare and contrast US FDA and China’s SFDA approval processes and highlight entry strategies for foreign companies seeking to establish a foothold in the lucrative Chinese market. In addition to best- and worst-case scenarios, Yu will address warehouse and logistics issues, quality control conundrums and cultural differences.
A well-known figure in China’s medical device industry, Yu is eager to share his first-hand experience with Chinese medical device manufacturers.
“I’d like to take it one step further at OrthoTec Europe 2012 by not only providing advice on regulatory matters, but by delivering strategic insights,” notes Yu. “It will be my great pleasure to provide some professional suggestions to foreign medical device manufacturers on how they can avoid common pitfalls when entering the Chinese market.”